Select Region or Location
Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • Other Americas
Europe
  • Austria
  • Belgium
  • Bulgaria
  • Croatia/Hrvatska
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovak Republic
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • Other Europe
Asia Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Korea, Republic of
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Other Asia Pacific
Africa And Middle East
  • Egypt
  • Israel
  • Other Africa And Middle East
USD
Home Cart Sign in  
Chemical Structure| 229971-81-7 Chemical Structure| 229971-81-7

Structure of ADH-1
CAS No.: 229971-81-7

Chemical Structure| 229971-81-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Exherin is a small, cyclic pentapeptide vascular-targeting agent with potential antineoplastic and antiangiogenic activities and selectively and competitively binds to and blocks N-cadherin.

Synonyms: N-Ac-CHAVC-NH2;Exherin

4.5 *For Research Use Only! Not for Human Use. We Do Not Sell to Patients.

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]}{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}
    {[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ADH-1

CAS No. :229971-81-7
Formula : C22H34N8O6S2
M.W : 570.69
SMILES Code : O=C([C@@H](NC([C@H](C(C)C)NC([C@H](C)NC([C@H](CC1=CN=CN1)N2)=O)=O)=O)CSSC[C@H](NC(C)=O)C2=O)N
Synonyms :
N-Ac-CHAVC-NH2;Exherin
English Name :(4R,7S,10S,13S,16R)-13-((1H-Imidazol-5-yl)methyl)-16-acetamido-7-isopropyl-10-methyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraazacycloheptadecane-4-carboxamide
MDL No. :MFCD18251730
InChI Key :FQVLRGLGWNWPSS-BXBUPLCLSA-N
Pubchem ID :9916058

Safety of ADH-1

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Fibroblasts (HCA2-hTERT) 1 mg/ml 12, 24 or 48 h ADH-1 had no effect on the survival of fibroblasts PLoS One. 2012;7(2):e31206
Human airway smooth muscle cells (HASM) 250 μg/ml 10 min To evaluate the effect of ADH-1 on F-actin remodeling in HASM cells, results showed that ADH-1 significantly reduced histamine-induced F-actin formation. Sci Adv. 2024 Nov 29;10(48):eadp8872
Human airway smooth muscle cells (HASM) 500 μg/ml 24 h To evaluate the effect of ADH-1 on HASM cell contractility, results showed that ADH-1 significantly inhibited histamine-induced cell contraction. Sci Adv. 2024 Nov 29;10(48):eadp8872
Human umbilical vein endothelial cells (HUVEC) 1mg/mL 1 hour To evaluate the effect of ADH-1 on HUVEC cell permeability. Results showed that ADH-1 treatment approximately doubled the permeability of HUVEC cells to 40kDa FITC-dextran. Ann Surg. 2015 Feb;261(2):368-77
MDA-MB-468 cells 40 µM 48 h To evaluate the effect of ADH-1 on the proliferation and attachment of MDA-MB-468 cells. Results showed that ADH-1 significantly inhibited the attachment of MDA-MB-468 cells. J Cell Mol Med. 2022 Apr;26(8):2392-2403
DU145 cells 40 µM 48 h To evaluate the effect of ADH-1 on the proliferation and attachment of DU145 cells. Results showed that ADH-1 had a weaker inhibitory effect on the attachment of DU145 cells. J Cell Mol Med. 2022 Apr;26(8):2392-2403
PC3 cells 40 µM 48 h To evaluate the effect of ADH-1 on the proliferation and attachment of PC3 cells. Results showed that ADH-1 significantly inhibited the proliferation and attachment of PC3 cells. J Cell Mol Med. 2022 Apr;26(8):2392-2403
SH-SY5Y cells 0.5 mg/ml 24 h Treatment with ADH-1 resulted in significant decrease of N-cadherin immunoreactivity at cell-cell contact sites J Biol Chem. 2011 Mar 4;286(9):7619-28
Epithelial cells (MCF-7) 1 mg/ml 12, 24 or 48 h ADH-1 had no effect on the survival of N-cadherin negative epithelial cells PLoS One. 2012;7(2):e31206
Neuroblastoma cell lines (CLB-GA, IMR32, SK-N-SH) 0.25; 0.50 or 1 mg/ml 12, 24 or 48 h ADH-1 strongly inhibited neuroblastoma cell proliferation in vitro by inducing apoptosis PLoS One. 2012;7(2):e31206

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice (Balb/c) Allergic airway inflammation model Intraperitoneal injection 200 mg/kg Single dose To evaluate the effect of ADH-1 on airway hyperresponsiveness in an allergic airway inflammation model, results showed that ADH-1 significantly reduced MCh-induced airway resistance. Sci Adv. 2024 Nov 29;10(48):eadp8872
NOD SCID gamma (NSG) mice PC3 tumor model Intraperitoneal injection 200 mg/kg 5 days a week To evaluate the adjuvant effect of ADH-1 on TIL-related therapy J Immunother Cancer. 2021 Mar;9(3):e002138.
Nude rats DM443 and A375 melanoma xenograft models Intraperitoneal injection 100 mg/kg Single injection To evaluate the effect of ADH-1 on melanoma xenograft models. Results showed that ADH-1 increased vascular permeability but did not significantly alter tumor interstitial fluid pressure. Additionally, ADH-1 increased LPAM delivery but had no significant effect on TMZ delivery. Ann Surg. 2015 Feb;261(2):368-77

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.75mL

0.35mL

0.18mL

8.76mL

1.75mL

0.88mL

17.52mL

3.50mL

1.75mL

References

 

Historical Records

Categories